Imjudo

Imjudo ATC Classification

tremelimumab

Manufacturer:

AstraZeneca

Distributor:

Zuellig

/

Four Star

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

L01FX20 - tremelimumab ; Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Exclusive offer for doctors

Continue with Google

Sign up with email

Already a member? Sign in